SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001103021-20-000104
Filing Date
2020-07-24
Accepted
2020-07-24 16:49:42
Documents
4
Period of Report
2020-07-24
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8kannualmeetingresult.htm 8-K 83415
2 EX-3.1 bdsi-formofcertificate.htm EX-3.1 10198
3 EX-3.2 bdsi-charteramendment7.htm EX-3.2 9599
4 image011.jpg GRAPHIC 162
  Complete submission text file 0001103021-20-000104.txt   104902
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31361 | Film No.: 201047363
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences